117 related articles for article (PubMed ID: 37605583)
21. Impact of genetic variants of IL-6, IL6R, LRP5, ESR1 and SP7 genes on bone mineral density in postmenopausal Mexican-Mestizo women with obesity.
Méndez JP; Rojano-Mejía D; Coral-Vázquez RM; Coronel A; Pedraza J; Casas MJ; Soriano R; García-García E; Vilchis F; Canto P
Gene; 2013 Oct; 528(2):216-20. PubMed ID: 23891823
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
Ghannam NN; Hammami MM; Bakheet SM; Khan BA
Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
[TBL] [Abstract][Full Text] [Related]
23. LRP5 polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis.
Zhou PR; Liu HJ; Liao EY; Zhang ZL; Chen DC; Liu J; Wu W; Xing XP; Xia WB; Xu L; Li M
Pharmacogenomics; 2014 Apr; 15(6):821-31. PubMed ID: 24897288
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD.
Chubachi S; Nakamura H; Sasaki M; Haraguchi M; Miyazaki M; Takahashi S; Tanaka K; Funatsu Y; Asano K; Betsuyaku T;
Respirology; 2015 Feb; 20(2):286-95. PubMed ID: 25392953
[TBL] [Abstract][Full Text] [Related]
25. Role of APOE Gene in Bone Mineral Density and Incidence of Bone Fractures in Brazilian Postmenopausal Women.
Souza LS; Rochette NF; Pedrosa DF; Magnago RPL; Filho TBF; Vieira FLH; Fin IDCF; Eis SR; Graceli JB; Rangel LBA; Silva IV
J Clin Densitom; 2018; 21(2):227-235. PubMed ID: 28784276
[TBL] [Abstract][Full Text] [Related]
26. Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis.
Tran BN; Nguyen ND; Eisman JA; Nguyen TV
BMC Med Genet; 2008 Jun; 9():55. PubMed ID: 18588671
[TBL] [Abstract][Full Text] [Related]
27. Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease.
Ismail MH; Al-Elq AH; Al-Jarodi ME; Azzam NA; Aljebreen AM; Al-Momen SA; Bseiso BF; Al-Mulhim FA; Alquorain A
Saudi J Gastroenterol; 2012; 18(3):201-7. PubMed ID: 22626800
[TBL] [Abstract][Full Text] [Related]
28. A C >T polymorphism located at position -1 of the Kozak sequence of CD40 gene is associated with low bone mass in Spanish postmenopausal women.
Pineda B; Laporta P; Hermenegildo C; Cano A; García-Pérez MA
Osteoporos Int; 2008 Aug; 19(8):1147-52. PubMed ID: 18097708
[TBL] [Abstract][Full Text] [Related]
29. Deterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long-Term Risk for Fragility Fracture: A Prospective Study.
Chapurlat R; Bui M; Sornay-Rendu E; Zebaze R; Delmas PD; Liew D; Lespessailles E; Seeman E
J Bone Miner Res; 2020 May; 35(5):833-844. PubMed ID: 31821619
[TBL] [Abstract][Full Text] [Related]
30. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
[TBL] [Abstract][Full Text] [Related]
31. Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study.
Xu Y; Shen L; Liu L; Zhang Z; Hu W
Front Endocrinol (Lausanne); 2022; 13():843912. PubMed ID: 35898467
[TBL] [Abstract][Full Text] [Related]
32. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
33. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
[TBL] [Abstract][Full Text] [Related]
34. Correlation of vitamin D receptor gene (VDR) polymorphism with osteoporotic changes in Polish postmenopausal women.
Seremak-Mrozikiewicz A; Drews K; Mrozikiewicz PM; Bartkowiak-Wieczorek J; Marcinkowska M; Wawrzyniak A; Slomski R; Kalak R; Czerny B; Horst-Sikorska W
Neuro Endocrinol Lett; 2009; 30(4):540-6. PubMed ID: 20010502
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor α and β gene polymorphism in relation to bone mineral density and lipid profile in Northeast Indian women.
Saoji R; Desai M; Das RS; Das TK; Khatkhatay MI
Gene; 2019 Aug; 710():202-209. PubMed ID: 31163192
[TBL] [Abstract][Full Text] [Related]
36. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.
He J; Zhang H; Wang C; Zhang Z; Yue H; Hu W; Gu J; Fu W; Hu Y; Li M; Liu Y; Zheng H; Zhang Z
J Clin Endocrinol Metab; 2014 Apr; 99(4):E665-73. PubMed ID: 24423318
[TBL] [Abstract][Full Text] [Related]
37. Association between SOST gene polymorphisms and response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.
Wang WJ; Fu WZ; He JW; Wang C; Zhang ZL
Pharmacogenomics J; 2019 Oct; 19(5):490-498. PubMed ID: 30287911
[TBL] [Abstract][Full Text] [Related]
38. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
[TBL] [Abstract][Full Text] [Related]
39. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
[TBL] [Abstract][Full Text] [Related]
40. Mean bone mineral density and frequency of occurrence of osteopenia and osteoporosis in patients on hemodialysis: a single-center study.
Khan MI; Syed GM; Khan AI; Sirwal IA; Anwar SK; Al-Oufi AR; Balbaid KA
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):38-43. PubMed ID: 24434380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
